arXiv:2507. 20993v4 Announce Type: replace-cross Abstract: We study how to learn treatment policies from multimodal electronic health records (EHRs) that consist of tabular data and clinical text.
By Henri Arno, Thomas Demeester
arXiv:2604. 23904v3 Announce Type: replace-cross Abstract: Synthetic tabular data are often evaluated by distributional similarity, privacy distance, or train-on-synthetic-test-on-real predictive performance, but these criteria do not ensure validity for causal inference.
By Yichen Xu
arXiv:2603. 19186v3 Announce Type: replace Abstract: Randomized controlled trials (RCTs) are the gold standard for estimating treatment effects, yet they are often underpowered for detecting effect heterogeneity.
By Amir Asiaee, Samhita Pal
arXiv:2607. 27224v1 Announce Type: cross Abstract: External and synthetic control arms (ECAs) are entering psychiatric drug development, but the field lacks a benchmark that evaluates the properties regulators care about: not only how accurately a method reconstructs untreated trajectories, but whether its uncertainty is calibrated, whether it is robust to the informative observation times common in mental-health records (sicker patients are seen more often), and what false-positive rate it induces in go/no-go trial decisions.
By Aakash Bhagat, Shashank Choudhary
arXiv:2606. 17113v1 Announce Type: new Abstract: Distinguishing causal adverse drug events (ADEs) from spurious correlations remains a central challenge in pharmacovigilance.
By Csaba Kiss, Roland Molontay, Gabriele Pergola
arXiv:2606. 05797v1 Announce Type: new Abstract: Longitudinal treatment decisions require predicting potential outcomes under future treatment sequences in the presence of time-varying confounding, heterogeneous patient dynamics, and limited domain-specific data.
By Amirhossein Zare, Amirhessam Zare, Herlock Rahimi, Reza Salarikia, Mohammad Kashkooli